Pseudomyogenic Hemangioendothelioma.
Al-Qaderi A, Mansour AT.
Arch Pathol Lab Med. 2019 Jun;143(6):763-767. doi: 10.5858/arpa.2017-0430-RS. Epub 2018 Dec 21.
New kids on the block: FOSFOSB gene.
Cordier F, Creytens D.
J Clin Pathol. 2023 Nov;76(11):721-726. doi: 10.1136/jcp-2023-208931. Epub 2023 Aug 8.
Primary pseudomyogenic haemangioendothelioma of the testis with a novel POTEI::FOSB gene fusion.
Gersmann AK, Haller F, Behnert N, Richter A, Stöhr R, Hartmann A, Ströbel P, Bremmer F.
Histopathology. 2022 Sep;81(3):411-414. doi: 10.1111/his.14697. Epub 2022 May 27.
Pseudomyogenic hemangioendothelioma.
Horan NA, DiMaio DJ.
Cutis. 2017 Dec;100(6):E13-E16.
Pseudomyogenic Hemangioendothelioma.
Ansai SI, Morimoto M, Akaishi S.
J Nippon Med Sch. 2019;86(2):126-130. doi: 10.1272/jnms.JNMS.2019_86-209.
Pseudomyogenic Hemangioendothelioma (Epithelioid Sarcoma-Like Hemangioendothelioma).
Caballero GA, Roitman PD.
Arch Pathol Lab Med. 2020 Apr;144(4):529-533. doi: 10.5858/arpa.2018-0395-RS. Epub 2019 Apr 24.
An aggressive case of pseudomyogenic haemangioendothelioma of bone with pathological fracture and rapidly progressive pulmonary metastatic disease: case report and review of the literature.
Shah AR, Fernando M, Musson R, Kotnis N.
Skeletal Radiol. 2015 Sep;44(9):1381-6. doi: 10.1007/s00256-015-2168-7. Epub 2015 May 17.
The 2020 WHO Classification: What's New in Soft Tissue Tumor Pathology?
Kallen ME, Hornick JL.
Am J Surg Pathol. 2021 Jan;45(1):e1-e23. doi: 10.1097/PAS.0000000000001552.
Primary pseudomyogenic haemangioendothelioma of bone.
Sheng WQ, Wang J.
Histopathology. 2012 Dec;61(6):1219-24. doi: 10.1111/j.1365-2559.2012.04347.x. Epub 2012 Sep 11.
Novel EGFL7-FOSB fusion in pseudomyogenic haemangioendothelioma with widely metastatic disease.
Hakar MH, White K, Hansford BG, Swensen J, Davis JL.
Histopathology. 2021 Nov;79(5):888-891. doi: 10.1111/his.14349. Epub 2021 Sep 3.
